Otilimab
- Generic Name
- Otilimab
- Drug Type
- Biotech
- CAS Number
- 1638332-55-4
- Unique Ingredient Identifier
- Y8127R3VCH
Overview
Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).
Background
Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).
Indication
Investigated for use/treatment in inflammatory disorders (unspecified).
Associated Conditions
No associated conditions information available.
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath